Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
NanoVibronix ( (NAOV) ) has provided an update.
On December 12, 2025, NanoVibronix, Inc. officially changed its name to ENvue Medical, Inc. and updated its Nasdaq ticker symbol from ‘NAOV’ to ‘FEED’ to align with its strategic focus on the ENvue® feeding-tube placement system. This rebranding reflects the company’s shift towards scaling hospital utilization and building a comprehensive enteral-feeding ecosystem, marking a new phase of growth and clinical excellence. The changes do not affect the rights of security holders, and no action is required from current stockholders.
More about NanoVibronix
NanoVibronix, Inc., now rebranded as ENvue Medical, Inc., is a medical technology company that specializes in non-invasive and minimally invasive therapeutic systems. The company focuses on acoustic-based therapeutic technologies, such as PainShield® and UroShield®, and the ENvue™ Navigation Platform, which is designed to assist in the placement of feeding tubes. Headquartered in Tyler, Texas, with R&D in Nesher, Israel, the company aims to innovate in patient safety and clinical usability across healthcare settings.
Average Trading Volume: 994,527
Technical Sentiment Signal: Strong Sell
Current Market Cap: $4.69M
Find detailed analytics on NAOV stock on TipRanks’ Stock Analysis page.